Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Membranous Nephropathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04743739
What this trial is testing

Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN

Who this might be right for
Idiopathic Membranous Nephropathy
Peking Union Medical College Hospital 12
Not applicableLooking for participantsNCT05505500
What this trial is testing

Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.

Who this might be right for
Fluid OverloadGlomerulosclerosis, Focal SegmentalEdema+10 more
University of Michigan 150
Very early researchStudy completedNCT00405340
What this trial is testing

Rituximab in the Treatment of Idiopathic Membranous Nephropathy

Who this might be right for
Membranous Nephropathy
Mayo Clinic 20
Large-scale testing (Phase 3)Looking for participantsNCT05696613
What this trial is testing

SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Cerium Pharmaceuticals, Inc. 148
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07029139
What this trial is testing

Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Shanghai JMT-Bio Inc. 156
Large-scale testing (Phase 3)Active Not RecruitingNCT04629248
What this trial is testing

A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Hoffmann-La Roche 142
Very early researchNot Yet RecruitingNCT07535138
What this trial is testing

Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)IgA Nephropathy (IgAN)
Air Force Military Medical University, China 15
Post-approval studies (Phase 4)Study completedNCT00843856
What this trial is testing

Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis

Who this might be right for
Glomerulonephritis, Membranous
Imperial College Healthcare NHS Trust 40
Not applicableUnknownNCT05861869
What this trial is testing

Clinical Trial of PLA2R-IgG4 Detection Kit (Time-resolved Fluorescence Immunoassay)

Who this might be right for
Membranous Nephropathy - PLA2R InducedKidney Diseases-except Membranous Nephropathy
Zhejiang Biostar Biotechnology Co. 450
Not applicableStudy completedNCT07702981
What this trial is testing

Immunophenotyping Profiling in Patients With Primary Nephrotic Syndrome

Who this might be right for
Membranous NephropathyMinimal Change Disease (MCD)Focal Segmental Glomerulosclerosis (FSGS)
University Hospital, Ioannina 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06642909
What this trial is testing

A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
BioRay Pharmaceutical Co., Ltd. 135
Not applicableNot Yet RecruitingNCT07416942
What this trial is testing

Omics of Rituximab-resistance

Who this might be right for
Membranous Nephropathy
Mario Negri Institute for Pharmacological Research 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05732402
What this trial is testing

An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

Who this might be right for
Lupus NephritisImmunoglobulin A NephropathyMembranous Nephropathy+1 more
Alpine Immune Sciences, Inc. 72
Post-approval studies (Phase 4)Study completedNCT04424862
What this trial is testing

Multitarget Therapy for Idiopathic Membranous Nephropathy

Who this might be right for
Efficacy
Beijing Friendship Hospital 82
Large-scale testing (Phase 3)Study completedNCT01508468
What this trial is testing

Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Assistance Publique - Hôpitaux de Paris 80
Large-scale testing (Phase 3)Looking for participantsNCT06470191
What this trial is testing

A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.

Who this might be right for
Primary Membranous Nephropathy
Shanghai Jiaolian Drug Research and Development Co., Ltd 216
Not applicableLooking for participantsNCT05036850
What this trial is testing

China Kidney Patient Trials Network

Who this might be right for
Kidney Diseases
George (Beijing) Clinical Research Co. Ltd. 1,200
Post-approval studies (Phase 4)Study completedNCT01386554
What this trial is testing

Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients

Who this might be right for
ProteinuriaIdiopathic Membranous Nephropathy
Mallinckrodt 60
Very early researchNot Yet RecruitingNCT06690359
What this trial is testing

IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients

Who this might be right for
IgA NephropathyMembranous Nephropathy
Beijing Immunochina Medical Science & Technology Co., Ltd. 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07721363
What this trial is testing

Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II Trial

Who this might be right for
Lupus NephritisMembranous Nephropathy
Assistance Publique - Hôpitaux de Paris 65
Next Page